Comparative effectiveness research in the United States: a progress report
- PMID: 23227997
- DOI: 10.3111/13696998.2012.754613
Comparative effectiveness research in the United States: a progress report
Abstract
The United States, with vast resources devoted to medical care, is investing in a new approach designed to improve health care efficiency. The conduct and reporting of comparative effectiveness research (CER) promises to help clinicians, payers, patients and other stakeholders make better and more informed decisions. Expectations for CER are high and public and private investments are sizeable. This paper discussions the evolution of CER in the US and gives a brief report on its progress and challenges.
Similar articles
-
Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison.Issue Brief (Commonw Fund). 2010 Jul;91:1-14. Issue Brief (Commonw Fund). 2010. PMID: 20614655
-
Maximizing the clinical utility of comparative effectiveness research.Clin Pharmacol Ther. 2010 Dec;88(6):876-9. doi: 10.1038/clpt.2010.200. Epub 2010 Oct 20. Clin Pharmacol Ther. 2010. PMID: 20962776 Review.
-
The impact of comparative effectiveness research on interventional pain management: evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute.Pain Physician. 2011 May-Jun;14(3):E249-82. Pain Physician. 2011. PMID: 21587337 Review.
-
The implications of comparative effectiveness research for academic medicine.Acad Med. 2011 Jun;86(6):684-8. doi: 10.1097/ACM.0b013e318217e941. Acad Med. 2011. PMID: 21512362
-
What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.J Comp Eff Res. 2013 Jul;2(4):461-77. doi: 10.2217/cer.13.42. J Comp Eff Res. 2013. PMID: 24236686
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
